Gilead prices COVID-19 drug candidate remdesivir at $2,340 per patient

Gilead Sciences Inc has priced its COVID-19 drug candidate remdesivir at $2,340 for a five-day treatment in the United States and some other developed countries, potentially reflecting looming competition from a cheap steroid.

The price tag is below the $5,080 per course recommendation by U.S. drug pricing research group, the Institute for Clinical and Economic Review (ICER), last week.

https://www.yahoo.com/finance/news/gilead-prices-covid-19-drug-111703247.html
 

We are a long way off from a vaccine and don't think if it is approved that it will work. Sometime next year some of them may be approved however unlikely but what if they work on only 50% of the people or what if they work only temporarily? Vaccine research and approval and distribution typically takes 10-12 years. What if these high prices hold so many cannot afford them? What then?
 

They get away with murder when it comes to medications. My mother's Xeljanz for her RA is $3000 a month. She had to apply for assistance. She gets $9000 of medication for free every 3 months. Otherwise she would be unable to function.
 
This is exactly why hydroxychloroquine given in conjunction with zinc and axithromycin has not been properly studied. A Lancet study showing adverse outcomes using HCQ has been retracted due to flawed data. Other studies have waited until patients were in ICU to begin therapy and a couple of others I read gave HCQ in doses much higher than recommended. Very few studies have included zinc.

When NYU's Grossman School of Medicine showed effective results, it was hardly covered at all in the media. NYU did a retrospective study of 932 COVID-19 patients treated at local hospitals with hydroxychloroquine and azithromycin and found that patients given hydroxychloroquine along with zinc sulphate and the antibiotic azithromycin were 44 percent less likely to die from the coronavirus. Researchers said the patients given zinc were one and a half times more likely to recover, decreasing their need for intensive care.

Pharmaceutical companies do not want a 40 year old generic drug that's GRS (generally regarded as safe) to work. They want a $2,340.00 treatment regimen instead. Not too hard to figure out why...
 
Last edited:
There is little doubt, in my mind, that if/when a cure is found for this virus, it is going to be Very Expensive. The drug companies are probably working 24/7 on a cure, and running up huge expenses....which they Will recoup, several times over. Then, given all the extraordinary expenses this virus is creating for the entire HealthCare industry, we can probably expect that health insurance premiums will rise substantially beginning in the very near future. With so many seniors being affected, I would surmise that these costs will drive Medicare into financial troubles much sooner than predicted.

This virus is laying the groundwork for economic issues that will probably be with us for years.
 
I thought I heard someone say if you are put on it you already in deep poop probably on a ventilator in an icu so a few extra grand probably won't be the final blow to one's budget if it's still there.

But yes why the resistance to the hydroxy, antibiotic and zinc cocktails. One has to wonder who is really advocating resistance to those.
 
We'd better watch our step. If a drug company based outside the US develops a vaccine first, we may find ourselves at the bottom of the distribution list.

The international community is very clear that American ethics have eroded to the point of being nearly non-existent. (And I'm being generous when I use the word "nearly.")

That's exactly what will happen. Or they'll price gouge.

Many of those other countries should've worked to procure those drugs as hard as the US did. But many can't even a attempt such a feat.

Every country should be helping others without the economic or logistical capability to acquire these drugs and other supplies.
 

Back
Top